BDSX: Biodesix Inc Company Value to Net Income

Corporate emblem and logo of Biodesix Corp (BDSX)

Biodesix, Inc. (BDSX) possesses a powerful business moat driven by exclusive patents in AI analysis and liquid biopsy. A flawlessly optimized express delivery network for biomaterials ensures the accuracy of research. This price chart reflects a market trend for the asset with a value of -4.00, while the company's financial stability is strengthening through the expansion of insurance coverage for diagnostic services.

Biodesix Inc (BDSX): Price to Earnings Ratio from 07/04/2022 to 11/14/2026

Analytical breakdowns for Biodesix, Inc.

- share price and expert price forecast:
Price Performance Chart biodesix.com|BDSX - Consensus Target
- market capitalization information:
Market Value Biodesix, Inc.|BDSX - Enterprise Value
- balance sheet net asset value indicators:
Book Value per Share Biodesix|BDSX - Company Book Value|Capitalization to Book Value Ratio biodesix.com|BDSX - Company Total Assets
- debt and solvency information:
Total Debt to Capital Biodesix, Inc.|BDSX - Long-Term Debt to Equity|Short-Term Debt to Equity Biodesix Corporation|BDSX - Company Total Debt|Debts to Book Value Biodesix, Inc.|BDSX - Company Long-Term Debt|Short-Term Debt Volume Biodesix|Interim Coverage Ratio biodesix.com
- net income and valuation ratios data:
BDSX - Company Net Income|Company Profit Forecast Biodesix, Inc.|BDSX - P/E Multiple|Future Price to Earnings Biodesix Inc|BDSX - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Biodesix, Inc.|BDSX - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Biodesix|BDSX - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last 12 months biodesix.com|BDSX - Earnings growth in current year|Expected net earnings per share growth next year Biodesix, Inc.
- sales volume and revenue indicators:
BDSX - Company Revenue|Company Future Sales biodesix.com|BDSX - P/S Multiple|Market Cap to Expected Sales Ratio Biodesix, Inc.
General company analysis:BDSX (biodesix.com)
Core merchandise of Biodesix Corporation

Investors assess the fundamental value of the business through the ratio of market capitalization to net income, determining the cost of one dollar of earnings. This calculation reflects the monetization efficiency of diagnostic tests and Biodesix, Inc. (BDSX) partnerships with oncology clinics, allowing the asset's overbought status or bankruptcy risks in the absence of real profit to be identified through changes in the company's P/E multiple.

Analysis of competing companies

CAI: Company Value to Net Income|Price to Earnings Ratio GH (Guardant Health)|VCYT (Veracyte Inc) - Company Value to Net Income|P/E Multiple CELC (Celcuity Corp)|P/E Multiple GRAIL Bio GRAL|MYGN - Price to Earnings Ratio|CSTL (castlebiosciences.com) - Price to Earnings Multiple|BNR: P/E Multiple|VolitionRx (VNRX) - P/E Multiple|Price to Earnings Ratio Precipio, Inc|Price to Earnings Ratio CHEK|Price to Earnings Ratio MYNZ (Mainz Biomed)|OCX - Market Cap to Earnings